OVERVIEW
Vic Market Research Co., Ltd. is pleased to announce the release of the “Global and Chinese Biologics and Biosimilars Market Insight Report 2025–2031.”
This comprehensive study is designed to provide a structured and in-depth analysis of the Biologics and Biosimilars industry, both domestically and internationally, with a focus on the following key areas:
1.An overview and assessment of the current development status and emerging trends in the Biologics and Biosimilars industry across global and Chinese markets.
2.Estimation of the overall market size of the Biologics and Biosimilars industry, along with a detailed analysis of market share by major countries.
3.Evaluation of the development potential within various segments of the Biologics and Biosimilars industry, analysis of downstream market demand, and an examination of the competitive landscape.
4.Identification and exploration of industry pain points, aiming to support stakeholders in addressing key challenges effectively.
This report integrates extensive desk research with qualitative interviews conducted with industry experts and insiders, ensuring both the objectivity and comprehensiveness of the findings and data.
The study provides a detailed examination of the production, consumption, import, and export dynamics of the Biologics and Biosimilars market in China. It also highlights key global and domestic manufacturers that play a significant role in the Chinese market, presenting core performance indicators such as sales volume, revenue, pricing, gross margin, and market share.
Furthermore, the report delivers a thorough analysis of segmented growth within the Biologics and Biosimilars product category, including differentiation by product types, pricing, sales, revenue, and application-specific market performance. Historical data from 2020 to 2024 is incorporated, with forward-looking projections extending through 2031.
In light of the significant uncertainty introduced by the U.S. tariff policy set to take effect in 2025, the report offers a dedicated analysis of its core impacts. This includes assessments of global and regional competitive dynamics, economic linkages, supply chain restructuring, and countries’ strategic responses. The report concludes with strategic recommendations and a forward-looking outlook for the Biologics and Biosimilars market.
1. Key Global Players in the Biologics and Biosimilars Industry:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
2.Global Biologics and Biosimilars Market, Segmented by Product Type:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Others
3. Global Biologics and Biosimilars Market, Segmented by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
4. Global Biologics and Biosimilars Market, by Geographical Region:
North America (USA and Canada)
Europe (Germany, UK, France, Italy and other European countries)
Asia-Pacific (China, Japan, Korea, Taiwan, Southeast Asia, India, etc.)
Latin America (Mexico and Brazil, etc.)
Middle East and Africa (Turkey and Saudi Arabia, etc.)
I. Biologics and Biosimilars Market Overview:
1.1 Product Definition and Statistical Scope
1.2 On the basis of different product types, Biologics and Biosimilars can be mainly categorized as follows:
Global Growth Trend of Biologics and Biosimilars by Product Type 2020 VS 2024 VS 2031
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Others
1.3 From different applications, Biologics and Biosimilars mainly includes the following:
Global Different Applications Biologics and Biosimilars Growth Trend 2020 VS 2024 VS 2031
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
1.4 Global Biologics and Biosimilars Development Status and Future Trends (2020-2031)
Global Market Biologics and Biosimilars Revenue and Growth Rate (2020-2031)
Global Market Biologics and Biosimilars Sales and Growth Rate (2020-2031)
II. Global Market Major Biologics and Biosimilars Manufacturers Analysis:
2.1 Global Market Key Manufacturers Biologics and Biosimilars Sales and Market Share
Global Market Key Manufacturers Biologics and Biosimilars Sales (2020-2025)
Global Market Major Manufacturers Biologics and Biosimilars Sales Market Share (2020-2025)
2.2 Global Market Key Manufacturers Biologics and Biosimilars Revenue and Market Share
Global Market Key Manufacturers Biologics and Biosimilars Revenue (2020-2025)
Global Market Key Manufacturers Biologics and Biosimilars Revenue Market Share (2020-2025)
Global Market Key Manufacturers Biologics and Biosimilars Revenue Ranking by 2024
2.3 Global Market Key Manufacturers Biologics and Biosimilars Price (2020-2025)
2.4 Global Market Major Manufacturers Biologics and Biosimilars Headquarter and Origin Distribution
2.5 Global Market Key Manufacturers Biologics and Biosimilars Establishment Date and Biologics and Biosimilars Commercialization Date
2.6 Global Market Major Manufacturers Biologics and Biosimilars Product Type and Application
2.7 Biologics and Biosimilars Industry Concentration, Competition Analysis
Biologics and Biosimilars Industry Concentration Analysis: Global Top 5 Manufacturers Market Share by 2024
Global Market Biologics and Biosimilars First Tier, Second Tier and Third Tier Manufacturers (Brand) and Market Share in 2024.
2.8 New Investments and Market M&A Activities
III. Profiles of the following key players:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
1. Basic Information, Biologics and Biosimilars Manufacturing Base, Headquarters, Competitors and Market Position.
2. Biologics and Biosimilars Product Specifications, Parameters, and Market Applications .
3. Biologics and Biosimilars Sales, Revenue, Price and Gross Margin in Global Market (2020-2025).
4. Company Profile and Key Businesses.
5. Latest Company News.
IV. Analysis of Different Product Types of Biologics and Biosimilars:
4.1 Global Market Biologics and Biosimilars Sales by Product Type (2020-2031)
Global Market Sales and Market Share of Biologics and Biosimilars by Product Type (2020-2025)
Global Market Sales Forecast of Biologics and Biosimilars by Different Product Types (2026-2031)
4.2 Global Market Biologics and Biosimilars Size by Product Type (2020-2031)
Global Market Biologics and Biosimilars Size and Market Share by Product Type (2020-2025)
Global Market Size Forecast of Biologics and Biosimilars by Product Type (2026-2031)
4.3 Global Market Price Trend of Biologics and Biosimilars by Product Type (2020-2031)
V. Analysis of Biologics and Biosimilars for Different Applications
5.1 Global Market Sales of Biologics and Biosimilars by Application (2020-2031)
Global Market Biologics and Biosimilars Sales and Market Share by Application (2020-2025)
Global Market Biologics and Biosimilars Sales Forecast by Application (2026-2031)
5.2 Global Market Biologics and Biosimilars Size and Market Share by Application (2020-2025)
Global Market Biologics and Biosimilars Size Forecast by Application (2026-2031)
5.3 Global Market Price Trend of Biologics and Biosimilars by Application (2020-2031)
VI. Industry Development Environment Analysis
6.1 Development Analysis of Biologics and Biosimilars Industry - Development Trend
6.2 Biologics and Biosimilars Industry Development Analysis - Manufacturer Barriers
6.3 Biologics and Biosimilars Industry Development Analysis - Driving Factors
6.4 Biologics and Biosimilars Industry Development Analysis - Restraints
6.5 SWOT Analysis of Biologics and Biosimilars Global Companies
6.6 Biologics and Biosimilars Industry Development Analysis - Industry Policies
Industry Authorities and Regulatory Framework
Industry-related Policy Trends
Industry Related Planning
VII. Industry Supply Chain Analysis
7.1 Industry Chain Introduction of Biologics and Biosimilars Industry
7.2 Biologics and Biosimilars Industry Chain Analysis - Upstream
7.3 Biologics and Biosimilars Industry Chain Analysis - Midstream
7.4 Biologics and Biosimilars Industry Chain Analysis - Downstream
7.5 Procurement Mode of Biologics and Biosimilars Industry
7.6 Production Mode of Biologics and Biosimilars Industry
7.7 Biologics and Biosimilars Industry Sales Model and Sales Channels
VIII. Global Local Biologics and Biosimilars Capacity, Production Analysis
8.1 Global Biologics and Biosimilars Supply and Demand Status and Forecast (2020-2031)
Global Biologics and Biosimilars Capacity, Production, Capacity Utilization and Development Trend (2020-2031)
Global Biologics and Biosimilars Production, Market Demand and Development Trend (2020-2031)
8.2 Global Biologics and Biosimilars Import and Export Analysis
Global Market Biologics and Biosimilars Main Import Sources
Global Market Biologics and Biosimilars Main Export Destinations
IX. Research Findings and Conclusion
X. Appendix
10.1 Research Methodology
10.2 Data Sources
Secondary Information Sources
Primary Information Sources
10.3 Data Interactive Validation
10.4 Disclaimer”
Table of Contents
Table : Growth Trends in Biologics and Biosimilars by Product Type
Table:Growth Trend of Different Applications
Table:Current Development Status of Biologics and Biosimilars Industry
Table:Development Trend of Biologics and Biosimilars
Table:Global Major Regions Production of Biologics and Biosimilars
Table:Global Major Regions Biologics and Biosimilars Production Market Share
Table:Global Market Major Manufacturers Biologics and Biosimilars Production Capacity
Table:Global Market Major Manufacturers Biologics and Biosimilars Sales, Sales Market Share, Sales Revenue
Table:Global Market Major Manufacturers Biologics and Biosimilars Sales Revenue Market Share, Price
Table: Global Key Manufacturers Biologics and Biosimilars Revenue Ranking by 2025
Table: China Market Major Manufacturers Biologics and Biosimilars Sales, Sales Market Share, Sales Revenue
Table: China Market Key Manufacturers Biologics and Biosimilars Sales Revenue Market Share, Sales Price
Table: China Key Manufacturers Biologics and Biosimilars Revenue Ranking by 2025
Table: Global Major Manufacturers Biologics and Biosimilars Production Distribution and Commercialization Date
Table:Global Major Manufacturers Biologics and Biosimilars Product Type List
Table: Global Key Manufacturers Market Position of Biologics and Biosimilars in 2025 (First Tier, Second Tier and Third Tier)
Table: Global Biologics and Biosimilars Market Analysis of Current Status of Investments, Mergers & Acquisitions, and Others
Table: Global Major Regions Biologics and Biosimilars Sales Revenue
Table: Global Major Regions Biologics and Biosimilars Sales Revenue Market Share
Table: Global Major Regions Biologics and Biosimilars Revenue Market Share
Table: Global Major Regions Biologics and Biosimilars Sales Volume
Table: Global Major Regions Biologics and Biosimilars Sales Market Share
Table : Global Major Regions Biologics and Biosimilars Sales Share
Table : The following companies:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Biologics and Biosimilars Manufacturing Base, Sales Area, Competitors and Market Position
Biologics and Biosimilars Product Specifications, Parameters and Market Applications
Biologics and Biosimilars Sales, Revenue, Price and Gross Margin
Company Profile and Major Businesses
Latest Company News
Table: Global Sales of Biologics and Biosimilars by Product Type
Table: Global Sales Market Share of Biologics and Biosimilars by Product Type
Table: Global Sales Forecast of Biologics and Biosimilars by Product Type
Table: Global Sales Market Share Forecast of Biologics and Biosimilars by Product Type
Table: Global Revenue of Biologics and Biosimilars by Product Type
Table: Global Biologics and Biosimilars Revenue Market Share by Product Type
Table: Global Revenue Forecast of Biologics and Biosimilars by Product Type
Table: Global Revenue Market Share Forecast of Biologics and Biosimilars by Product Type
Table: Global Price Trend of Biologics and Biosimilars by Product Type
Table: Global Sales of Biologics and Biosimilars by Application
Table: Global Sales Market Share of Biologics and Biosimilars by Application
Table: Global Sales Forecast of Biologics and Biosimilars by Application
Table: Global Biologics and Biosimilars Sales Market Share Forecast by Application
Table: Global Biologics and Biosimilars Revenue by Application
Table: Global Biologics and Biosimilars Revenue Market Share by Application
Table: Global Biologics and Biosimilars Revenue Forecast by Application
Table: Global Biologics and Biosimilars Revenue Market Share Forecast by Application
Table: Global Price Trend of Biologics and Biosimilars by Application
Table: List of Biologics and Biosimilars Upstream Raw Material Suppliers and Contact Information
Table: List of Typical Customers of Biologics and Biosimilars
Table: Biologics and Biosimilars Main Sales Modes and Sales Channels
Table: Development Opportunities and Key Driving Factors of Biologics and Biosimilars Industry
Table: Risks Faced by Biologics and Biosimilars Industry Development
Table: Biologics and Biosimilars Industry Policy Analysis
Table: Research Scope
Table: List of Analysts
Chart Catalog
Figure Biologics and Biosimilars Product Picture
Figure Global Production Market Share of Biologics and Biosimilars by Product Type
Figure Global Biologics and Biosimilars Consumption Market Share by Application
Figure Global Biologics and Biosimilars Capacity, Production, Capacity Utilization and Development Trend
Figure Global Biologics and Biosimilars Production, Demand and Development Trend
Figure Global Biologics and Biosimilars Production Market Share by Major Regions
Figure China Biologics and Biosimilars Capacity, Production, Capacity Utilization and Development Trend
Figure China Biologics and Biosimilars Production, Market Demand and Development Trend
Figure Global Biologics and Biosimilars Market Sales and Growth Rate.
Figure Global Biologics and Biosimilars Market Size
Figure Global Market Biologics and Biosimilars Sales and Growth Rate
Figure Global Market Biologics and Biosimilars Price Trend
Figure Global Market Biologics and Biosimilars Sales Market Share of Major Manufacturers in 2025
Figure Biologics and Biosimilars Revenue Market Share of Key Manufacturers in Global Market in 2025
Figure Biologics and Biosimilars Sales Market Share of Key Manufacturers in China Market in 2025
Figure Biologics and Biosimilars Revenue Market Share of Key Manufacturers in China Market, 2025
Figure 2025 Global Biologics and Biosimilars Market Share of Top 5 Manufacturers
Figure 2025 Global Biologics and Biosimilars First Tier, Second Tier and Third Tier Manufacturers (by Brand) and Market Share
Figure Global Biologics and Biosimilars Sales Revenue Market Share by Major Regions
Figure North America Biologics and Biosimilars Sales and Growth Rate
Figure North America Biologics and Biosimilars Revenue and Growth Rate
Figure Europe Market Biologics and Biosimilars Sales and Growth Rate
Figure Europe Market Biologics and Biosimilars Revenue and Growth Rate
Figure China Biologics and Biosimilars Sales and Growth Rate
Figure China Market Biologics and Biosimilars Revenue and Growth Rate
Figure Biologics and Biosimilars Sales and Growth Rate in Japan Market
Figure Biologics and Biosimilars Revenue and Growth Rate in Japan Market
Figure Global Price Trend of Biologics and Biosimilars by Product Type
Figure Global Price Trend of Biologics and Biosimilars by Application
Figure Biologics and Biosimilars Industry Chain
Figure Biologics and Biosimilars Chinese Companies SWOT Analysis
Figure Key Interview Objectives
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
2025-04-19 11:27:50 
Pages: 127 
Tables: 142 
